Video

HER2 Positive Breast Cancer

HER2 Positive Breast Cancer : Reviewing Abstracts Published by Authors Anna van der Voort & Javier Cortes

Speaker :

Dr. Seema Gulia, Medical Oncologist, Mumbai

Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines  in the presence of dual HER2-blockade for HER2-positive breast cancer (TRAIN-2): A  randomized phase III trial

Author: Anna van der Voort

Citation :ASCO Abstract 501 

Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological  response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial

Author: Javier Cortes 

Citation: ASCO Abstract 503